medigraphic.com
ISSN 2500-7106 (Digital)
ISSN 0123-2576 (Impreso)
Medicina & Laboratorio

2022, Número 2

<< Anterior Siguiente >>

Medicina & Laboratorio 2022; 26 (2)


La trazabilidad en las mediciones del laboratorio clínico: impacto en la calidad y seguridad del paciente

Guevara-Arismendy NM, Cruz-Parra LM, Valencia-Villegas AA, Romero-Herrera E, Quiroz-Arias C, Arenas-Hernández ME, Salcedo-Cifuentes M

Idioma: Español
Referencias bibliográficas: 48
Paginas: 159-175
Archivo PDF: 121.38 Kb.


RESUMEN

Las mediciones confiables, trazables metrológicamente y comparables proporcionan la base racional para la evaluación de la calidad de un resultado y el fortalecimiento de las redes de laboratorios clínicos, lo cual permite mejorar la calidad de atención y la seguridad del paciente. En este documento se revisan los principios básicos que deben seguirse para garantizar la trazabilidad de las mediciones del laboratorio clínico, las ventajas de utilizar métodos trazables, el impacto de no hacerlo, y se discuten las principales limitaciones para relacionar las mediciones con los estándares de medición de referencia apropiados.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Monach PA. Repeating tests: different roles inresearch studies and clinical medicine. BiomarkMed 2012;6:691-703. https://doi.org/10.2217/bmm.12.57.

  2. International Organization for Standardization(ISO). ISO/IEC Guide 99:2007. Internationalvocabulary of metrology--Basic andgeneral concepts and associated terms (VIM).Ginebra, Suiza: ISO; 2007. Acceso 13 de enerode 2022. Disponible en https://www.iso.org/standard/45324.html.

  3. International Organization for Standardization/International Electrotechnical Commission(ISO-IEC). GTC-ISO-IEC 99:2019. Vocabulariointernacional de metrología. Conceptosfundamentales, generales y términos asociados(VIM). Bogotá, Colombia: Instituto Colombianode Normas Técnicas y Certificación (ICONTEC)Internacional; 2019. Acceso 12 de enero de2022. Disponible en https://tienda.icontec.org/gp-vocabulario-internacional-de-metrologiaconceptos-fundamentales-generales-y-terminos-asociados-vim-gtc-iso-iec99-2019.html.

  4. Beastall GH. Traceability in laboratory medicine:What is it and why is it important for patients?Ejifcc 2018;29:242-247.

  5. Cobbaert C, Smit N, Gillery P. Metrologicaltraceability and harmonization of medical tests:a quantum leap forward is needed to keeppace with globalization and stringent IVD-regulationsin the 21st century! Clin Chem Lab Med2018;56:1598-1602. https://doi.org/10.1515/cclm-2018-0343.

  6. Armbruster D, Donnelly J. Harmonization ofclinical laboratory test results: The role of theIVD industry. Ejifcc 2016;27:37-47.

  7. International Organization for Standardization(ISO). ISO 21151:2020. In vitro diagnosticmedical devices-Requirements for internationalharmonisation protocols establishing metrologicaltraceability of values assigned to calibratorsand human samples. Ginebra, Suiza: ISO;2020. Acceso 09 de enero de 2022. Disponibleen https://www.iso.org/standard/69985.html.

  8. International Organization for Standardization(ISO). ISO 17511:2020. In vitro diagnosticmedical devices-Requirements for establishingmetrological traceability of values assigned tocalibrators, trueness control materials and humansamples. Ginebra, Suiza: ISO; 2020. Acceso08 de enero de 2022. Disponible en https://www.iso.org/standard/69984.html.

  9. Pessoa M, Ferreira O. Metrological traceabilityin clinical laboratory. J Bras PatolMed Lab 2016;52:157-164. https://doi.org/10.5935/1676-2444.20160028.

  10. White GH. Metrological traceability in clinicalbiochemistry. Ann Clin Biochem 2011;48:393-409. https://doi.org/10.1258/acb.2011.011079.

  11. European Parliament. Directive 98/79/EC ofthe European Parliament and of the Council of27 October 1998 on in vitro diagnostic medicaldevices. Off J Eur Union 1998;L 331:1-37.https://doi.org/http://eur-lex.europa.eu.

  12. Dati F. The new European directive on in vitrodiagnostics. Clin Chem Lab Med 2003;41:1289-1298. https://doi.org/10.1515/cclm.2003.196.

  13. Infusino I, Frusciante E, Braga F, PanteghiniM. Progress and impact of enzyme measurementstandardization. Clin Chem Lab Med2017;55:334-340. https://doi.org/10.1515/cclm-2016-0661.

  14. Schumann G, Bonora R, Ceriotti F, Clerc-Renaud P, Ferrero CA, Férard G, et al. IFCCprimary reference procedures for the measurementof catalytic activity concentrationsof enzymes at 37 degrees C. Part 2. Referenceprocedure for the measurement of catalyticconcentration of creatine kinase. ClinChem Lab Med 2002;40:635-642. https://doi.org/10.1515/cclm.2002.110.

  15. Schumann G, Bonora R, Ceriotti F, Clerc-Renaud P, Ferrero CA, Férard G, et al. IFCCprimary reference procedures for the measurementof catalytic activity concentrations ofenzymes at 37 degrees C. Part 3. Referenceprocedure for the measurement of catalyticconcentration of lactate dehydrogenase. ClinChem Lab Med 2002;40:643-648. https://doi.org/10.1515/cclm.2002.111.

  16. Schumann G, Bonora R, Ceriotti F, FérardG, Ferrero CA, Franck PF, et al. IFCC primaryreference procedures for the measurement ofcatalytic activity concentrations of enzymes at37 degrees C. International Federation of ClinicalChemistry and Laboratory Medicine. Part4. Reference procedure for the measurement ofcatalytic concentration of alanine aminotransferase.Clin Chem Lab Med 2002;40:718-724.https://doi.org/10.1515/cclm.2002.124.

  17. Schumann G, Bonora R, Ceriotti F, FérardG, Ferrero CA, Franck PF, et al. IFCC primaryreference procedures for the measurement ofcatalytic activity concentrations of enzymes at37 degrees C. International Federation of ClinicalChemistry and Laboratory Medicine. Part5. Reference procedure for the measurement ofcatalytic concentration of aspartate aminotransferase.Clin Chem Lab Med 2002;40:725-733.https://doi.org/10.1515/cclm.2002.125.

  18. Schumann G, Bonora R, Ceriotti F, FérardG, Ferrero CA, Franck PF, et al. IFCC primaryreference procedures for the measurement ofcatalytic activity concentrations of enzymes at37 degrees C. International Federation of ClinicalChemistry and Laboratory Medicine. Part6. Reference procedure for the measurementof catalytic concentration of gamma-glutamyltransferase.Clin Chem Lab Med 2002;40:734-738. https://doi.org/10.1515/cclm.2002.126.

  19. Schumann G, Aoki R, Ferrero CA, Ehlers G,Férard G, Gella FJ, et al. IFCC primary referenceprocedures for the measurement of catalyticactivity concentrations of enzymes at 37degrees C. Clin Chem Lab Med 2006;44:1146-1155. https://doi.org/10.1515/cclm.2006.212.

  20. Schumann G, Klauke R, Canalias F, Bossert-Reuther S, Franck PF, Gella FJ, et al. IFCCprimary reference procedures for the measurementof catalytic activity concentrations of enzymesat 37 °C. Part 9: reference procedure forthe measurement of catalytic concentration ofalkaline phosphatase International Federationof Clinical Chemistry and Laboratory Medicine(IFCC) Scientific Division, Committee on ReferenceSystems of Enzymes (C-RSE) (1)). ClinChem Lab Med 2011;49:1439-1446. https://doi.org/10.1515/cclm.2011.621.

  21. Siekmann L, Bonora R, Burtis CA, Ceriotti F,Clerc-Renaud P, Férard G, et al. IFCC primaryreference procedures for the measurement ofcatalytic activity concentrations of enzymes at37 degrees C. International Federation of ClinicalChemistry and Laboratory Medicine. Part 7.Certification of four reference materials for thedetermination of enzymatic activity of gammaglutamyltransferase,lactate dehydrogenase,alanine aminotransferase and creatine kinaseaccord. Clin Chem Lab Med 2002;40:739-745.https://doi.org/10.1515/cclm.2002.127.

  22. Le Bureau International des Poids et Mesures(BIPM). Database of higher-order referencematerials, measurement methods/proceduresand services. Saint-Cloud, France: BIPM.Acceso 9 de febrero de 2022. Disponible enhttps://www.bipm.org/jctlm/home.do.

  23. European Commission, Joint Research Centre(JRC). Catalogue for certified reference materialsof the European Commission's Joint ResearchCentre (JRC). Geel, Belgium: EuropeanCommission. Acceso 9 de febrero de 2022.Disponible en https://crm.jrc.ec.europa.eu/.

  24. Jansen R, Jassam N, Thomas A, Perich C,Fernandez-Calle P, Faria AP, et al. A category1 EQA scheme for comparison of laboratoryperformance and method performance: Aninternational pilot study in the framework ofthe Calibration 2000 project. Clin Chim Acta2014;432:90-98. https://doi.org/10.1016/j.cca.2013.11.003.

  25. Ricós C, Perich C, Boned B, González-Lao E,Diaz-Garzón J, Ventura M, et al. Standardizationin laboratory medicine: Two years' experiencefrom category 1 EQA programs in Spain.Biochem Med (Zagreb) 2019;29:010701.https://doi.org/10.11613/bm.2019.010701.

  26. Miller WG, Myers GL, Ashwood ER, KilleenAA, Wang E, Ehlers GW, et al. State of theart in trueness and interlaboratory harmonizationfor 10 analytes in general clinical chemistry.Arch Pathol Lab Med 2008;132:838-846.https://doi.org/10.5858/2008-132-838-sotait.

  27. Aloisio E, Frusciante E, Pasqualetti S, QuercioliM, Panteghini M. Traceability of alkalinephosphatase measurement may also vary considerablyusing the same analytical system: thecase of Abbott Architect. Clin Chem Lab Med2018;56:e135-e137. https://doi.org/10.1515/cclm-2017-1007.

  28. Ross JW, Miller WG, Myers GL, PraestgaardJ. The accuracy of laboratory measurements inclinical chemistry: a study of 11 routine chemistryanalytes in the College of American PathologistsChemistry Survey with fresh frozen serum,definitive methods, and reference methods.Arch Pathol Lab Med 1998;122:587-608.

  29. Lawson N, Lang T, Broughton A, Prinsloo P,Turner C, Marenah C. Creatinine assays: timefor action? Ann Clin Biochem 2002;39:599-602.https://doi.org/10.1177/000456320203900609.

  30. Panteghini M. Enzymatic assays for creatinine:time for action. Clin Chem Lab Med 2008;46:567-572. https://doi.org/10.1515/cclm.2008.113.

  31. Delanghe JR, Cobbaert C, Galteau MM, HarmoinenA, Jansen R, Kruse R, et al. Truenessverification of actual creatinine assays in theEuropean market demonstrates a disappointingvariability that needs substantial improvement.An international study in the frameworkof the EC4 creatinine standardization workinggroup. Clin Chem Lab Med 2008;46:1319-1325.https://doi.org/10.1515/cclm.2008.256.

  32. Drion I, Cobbaert C, Groenier KH, WeykampC, Bilo HJ, Wetzels JF, et al. Clinical evaluationof analytical variations in serum creatinine measurements:why laboratories should abandonJaffe techniques. BMC Nephrol 2012;13:133.https://doi.org/10.1186/1471-2369-13-133.

  33. Carobene A, Ceriotti F, Infusino I, FruscianteE, Panteghini M. Evaluation of the impact ofstandardization process on the quality of serumcreatinine determination in Italian laboratories.Clin Chim Acta 2014;427:100-106. https://doi.org/10.1016/j.cca.2013.10.001.

  34. Piéroni L, Delanaye P, Boutten A, BargnouxAS, Rozet E, Delatour V, et al. A multicentric evaluationof IDMS-traceable creatinine enzymaticassays. Clin Chim Acta 2011;412:2070-2075.https://doi.org/10.1016/j.cca.2011.07.012.

  35. Weykamp C. HbA1c: a review of analytical andclinical aspects. Ann Lab Med 2013;33:393-400.https://doi.org/10.3343/alm.2013.33.6.393.

  36. White NH, Sun W, Cleary PA, Danis RP, DavisMD, Hainsworth DP, et al. Prolonged effectof intensive therapy on the risk of retinopathycomplications in patients with type 1 diabetesmellitus: 10 years after the Diabetes Controland Complications Trial. Arch Ophthalmol2008;126:1707-1715. https://doi.org/10.1001/archopht.126.12.1707.

  37. U.K. Prospective Diabetes Study (UKPDS)Group. Intensive blood-glucose control withsulphonylureas or insulin compared with conventionaltreatment and risk of complications inpatients with type 2 diabetes (UKPDS 33). UKProspective Diabetes Study (UKPDS) Group.Lancet 1998;352:837-853.

  38. Braga F, Panteghini M. Standardization andanalytical goals for glycated hemoglobin measurement.Clin Chem Lab Med 2013;51:1719-1726. https://doi.org/10.1515/cclm-2013-0060.

  39. Krintus M, Panteghini M. Laboratory-relatedissues in the measurement of cardiac troponinswith highly sensitive assays. Clin Chem Lab Med2020;58:1773-1783. https://doi.org/10.1515/cclm-2020-0017.

  40. Greenberg N. Update on current conceptsand meanings in laboratory medicine --Standardization,traceability and harmonization.Clin Chim Acta 2014;432:49-54. https://doi.org/10.1016/j.cca.2013.12.045.

  41. Gallaher MP, Rivers-Mobley L, Klee GG,Schryver P. Planning report 04-1. The impactof calibration error in medical decisionmaking. National Institute of Standards & Technology,Chemical Science and TechnologyLaboratory (NIST); 2004. Acceso 15 de febrerode 2022. Disponible en https://www.nist.gov/system/files/documents/director/planning/report04-1.pdf.

  42. The National Institute for Biological Standardsand Control (NIBSC). WHO InternationalStandard 4th HIV-1 International StandardNIBSC code: 16/194 Instructions for use (Version5.0, Dated 30/11/2017). United Kingdom(UK): NIBSC. Acceso 08 de febrero de 2022.Disponible en https://www.nibsc.org/documents/ifu/16-194.pdf.

  43. Beastall GH, Brouwer N, Quiroga S, MyersGL. Traceability in laboratory medicine: a globaldriver for accurate results for patient care.Clin Chem Lab Med 2017;55:1100-1108.https://doi.org/10.1515/cclm-2017-0060.

  44. Terrez A. Trazabilidad metrológica, validaciónanalítica y consenso de resultados en la confiabilidaddel laboratorio clínico. Rev Mex PatolClin 2009;56:27-35.

  45. Panteghini M, Braga F. Implementation of metrologicaltraceability in laboratory medicine:where we are and what is missing. Clin ChemLab Med 2020;58:1200-1204. https://doi.org/10.1515/cclm-2019-1128.

  46. Koumantakis G. Traceability of measurementresults. Clin Biochem Rev 2008;29:S61-66.

  47. Vesper HW, Myers GL, Miller WG. Currentpractices and challenges in the standardizationand harmonization of clinical laboratory tests.Am J Clin Nutr 2016;104:S907-912. https://doi.org/10.3945/ajcn.115.110387.

  48. Jansen R, Schumann G, Baadenhuijsen H,Franck P, Franzini C, Kruse R, et al. Truenessverification and traceability assessment of resultsfrom commercial systems for measurementof six enzyme activities in serum: an internationalstudy in the EC4 framework of the Calibration2000 project. Clin Chim Acta 2006;368:160-167.https://doi.org/10.1016/j.cca.2005.12.033.




2020     |     www.medigraphic.com